[Personalized treatment in non-small cell lung cancer].

Subjects

Subjects :

Adenocarcinoma enzymology
Adenocarcinoma genetics
Adenocarcinoma secondary
Algorithms
Antineoplastic Agents therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bone Neoplasms drug therapy
Bone Neoplasms enzymology
Bone Neoplasms secondary
Carcinoma, Non-Small-Cell Lung enzymology
Carcinoma, Non-Small-Cell Lung genetics
Clinical Trials, Phase II as Topic statistics & numerical data
Crizotinib
ErbB Receptors genetics
Erlotinib Hydrochloride
Female
Genes, ras
Humans
Leiomyoma surgery
Lung Neoplasms enzymology
Lung Neoplasms genetics
Middle Aged
Neoplasm Proteins genetics
Neoplasms, Second Primary drug therapy
Neoplasms, Second Primary enzymology
Neoplasms, Second Primary genetics
Oncogene Proteins, Fusion genetics
Randomized Controlled Trials as Topic statistics & numerical data
Uterine Neoplasms surgery
Adenocarcinoma drug therapy
Carcinoma, Non-Small-Cell Lung drug therapy
ErbB Receptors antagonists & inhibitors
Lung Neoplasms drug therapy
Molecular Targeted Therapy
Neoplasm Proteins antagonists & inhibitors
Oncogene Proteins, Fusion antagonists & inhibitors
Precision Medicine
Protein Kinase Inhibitors therapeutic use
Pyrazoles therapeutic use
Pyridines therapeutic use
Quinazolines therapeutic use

Details

Language :

Spanish; Castilian

ISSN :

0034-8376

Volume :

64

Issue :

4

Database :

MEDLINE

Journal :

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Publication Type :

Academic Journal

Accession number :

23227588